Christoph Mathis Schempp (Christoph M Schempp, C M Schempp)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 7

Top Topics

Oxide Nanoparticles

Atopic Dermatitis

Top Venues

Dermatology and therapy

Contact dermatitis

The British journal of dermatology

This page only lists publications with an associated author ORCID identifier.

Publications

Sarah Marie Hoffmann, Anna Luisa Hartmann, Pablo Nieratschker, Michael Berthold Mussler, Christoph Mathis Schempp
Acute Systemic Toxicity Caused by Topical Application of EMLA Cream on a Leg Ulcer: Case Report and Review of Literature. Dermatology and therapy 14 (4) (2024)
Sarah Marie Hoffmann, Anna Luisa Hartmann, Pablo Nieratschker, Michael Berthold Mussler, Christoph Mathis Schempp
Acute Systemic Toxicity Caused by Topical Application of EMLA Cream on a Leg Ulcer: Case Report and Review of Literature. Dermatology and therapy 14 (4) (2024)
Sarah Marie Hoffmann, Anna Luisa Hartmann, Pablo Nieratschker, Michael Berthold Mussler, Christoph Mathis Schempp
Acute Systemic Toxicity Caused by Topical Application of EMLA Cream on a Leg Ulcer: Case Report and Review of Literature. Dermatology and therapy (2024)
Sarah Marie Hoffmann, Anna Luisa Hartmann, Pablo Nieratschker, Michael Berthold Mussler, Christoph Mathis Schempp
Acute Systemic Toxicity Caused by Topical Application of EMLA Cream on a Leg Ulcer: Case Report and Review of Literature. Dermatology and therapy 14 (4) (2024)
Sarah Marie Hoffmann, Anna Luisa Hartmann, Pablo Nieratschker, Michael Berthold Mussler, Christoph Mathis Schempp
Acute Systemic Toxicity Caused by Topical Application of EMLA Cream on a Leg Ulcer: Case Report and Review of Literature. Dermatology and therapy 14 (4) (2024)
Rita von Webern, Maja Mockenhaupt, Christoph Mathis Schempp
Bullous irritant contact dermatitis caused by the spitting palm, Euphorbia leuconeura BOISSIER. Contact dermatitis 87 (5) (2022)
Leonie Frommherz, Christoph Mathis Schempp, Cristina Has
Secukinumab for the treatment of SAM syndrome associated with desmoglein-1 deficiency. The British journal of dermatology 184 (4) (2020)